Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8303 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7852 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD7228 |
Approved |
0.761 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7557 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7528 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7528 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7528 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7485 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7416 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7415 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7348 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7345 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7305 |
Intermediate Similarity |
NPD37 |
Approved |
0.7262 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7258 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7232 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7091 |
Intermediate Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7062 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7059 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7016 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7016 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.6989 |
Remote Similarity |
NPD6535 |
Approved |
0.6989 |
Remote Similarity |
NPD6534 |
Approved |
0.6963 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6946 |
Remote Similarity |
NPD6273 |
Approved |
0.6944 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6939 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6931 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD6190 |
Approved |
0.6906 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6905 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD3764 |
Approved |
0.6889 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD7680 |
Approved |
0.6865 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD7819 |
Suspended |
0.686 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD5494 |
Approved |
0.6849 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6846 |
Remote Similarity |
NPD4198 |
Discontinued |
0.6839 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6836 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6823 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD7741 |
Discontinued |
0.6806 |
Remote Similarity |
NPD6779 |
Approved |
0.6806 |
Remote Similarity |
NPD6776 |
Approved |
0.6806 |
Remote Similarity |
NPD6782 |
Approved |
0.6806 |
Remote Similarity |
NPD6781 |
Approved |
0.6806 |
Remote Similarity |
NPD6780 |
Approved |
0.6806 |
Remote Similarity |
NPD6778 |
Approved |
0.6806 |
Remote Similarity |
NPD6777 |
Approved |
0.6797 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6788 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6788 |
Remote Similarity |
NPD7698 |
Approved |
0.6788 |
Remote Similarity |
NPD7697 |
Approved |
0.6786 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6779 |
Remote Similarity |
NPD5951 |
Approved |
0.6768 |
Remote Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.6759 |
Remote Similarity |
NPD6686 |
Approved |
0.6755 |
Remote Similarity |
NPD7516 |
Approved |
0.6751 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6751 |
Remote Similarity |
NPD7874 |
Approved |
0.675 |
Remote Similarity |
NPD7961 |
Discontinued |
0.6747 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6735 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6725 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6724 |
Remote Similarity |
NPD5402 |
Approved |
0.6718 |
Remote Similarity |
NPD7999 |
Approved |
0.6716 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.671 |
Remote Similarity |
NPD7507 |
Approved |
0.6707 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6701 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6689 |
Remote Similarity |
NPD7328 |
Approved |
0.6689 |
Remote Similarity |
NPD7327 |
Approved |
0.6689 |
Remote Similarity |
NPD969 |
Suspended |
0.6688 |
Remote Similarity |
NPD7319 |
Approved |
0.6687 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6686 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6667 |
Remote Similarity |
NPD6765 |
Approved |
0.6667 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD6764 |
Approved |
0.6667 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6667 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6647 |
Remote Similarity |
NPD7003 |
Approved |
0.6633 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6633 |
Remote Similarity |
NPD7801 |
Approved |
0.6633 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.663 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6623 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6623 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6612 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6611 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6611 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6611 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6609 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6608 |
Remote Similarity |
NPD5403 |
Approved |
0.6599 |
Remote Similarity |
NPD2182 |
Approved |
0.6599 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6592 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6592 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6588 |
Remote Similarity |
NPD5401 |
Approved |
0.6585 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6571 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6571 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.657 |
Remote Similarity |
NPD1653 |
Approved |
0.6566 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6564 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6559 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6558 |
Remote Similarity |
NPD8380 |
Approved |
0.6558 |
Remote Similarity |
NPD8335 |
Approved |
0.6558 |
Remote Similarity |
NPD7503 |
Approved |
0.6558 |
Remote Similarity |
NPD8033 |
Approved |
0.6558 |
Remote Similarity |
NPD8379 |
Approved |
0.6558 |
Remote Similarity |
NPD8378 |
Approved |
0.6558 |
Remote Similarity |
NPD8296 |
Approved |
0.6552 |
Remote Similarity |
NPD7411 |
Suspended |
0.6548 |
Remote Similarity |
NPD3750 |
Approved |
0.6543 |
Remote Similarity |
NPD6663 |
Approved |
0.6538 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6535 |
Remote Similarity |
NPD7930 |
Approved |
0.6534 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6534 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6524 |
Remote Similarity |
NPD6785 |
Approved |
0.6524 |
Remote Similarity |
NPD6784 |
Approved |
0.6517 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6514 |
Remote Similarity |
NPD1934 |
Approved |
0.651 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6506 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6497 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6494 |
Remote Similarity |
NPD8377 |
Approved |
0.6494 |
Remote Similarity |
NPD8294 |
Approved |
0.6491 |
Remote Similarity |
NPD2532 |
Approved |
0.6491 |
Remote Similarity |
NPD2534 |
Approved |
0.6491 |
Remote Similarity |
NPD2533 |
Approved |
0.6488 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6467 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6467 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6467 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6467 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6467 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6467 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6465 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6463 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6452 |
Remote Similarity |
NPD8513 |
Phase 3 |
0.6452 |
Remote Similarity |
NPD8515 |
Approved |
0.6452 |
Remote Similarity |
NPD8516 |
Approved |
0.6452 |
Remote Similarity |
NPD8517 |
Approved |
0.6447 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6446 |
Remote Similarity |
NPD3748 |
Approved |
0.6444 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6442 |
Remote Similarity |
NPD7714 |
Approved |
0.6442 |
Remote Similarity |
NPD7715 |
Approved |
0.6437 |
Remote Similarity |
NPD3226 |
Approved |
0.6433
|
Remote Similarity |
NPD6799 |
Approved |